Has Jose Ramirez, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,140 in general payments to Jose Ramirez, MD across 50 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jose Ramirez, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jose Ramirez, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jose Ramirez, MD

Vascular Surgery · Miami, FLNPI 1841239134

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,685 of the $3,140 with a category attached, or 85.5%. 15 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 26.2% of the total. Reporting peaked in 2022 at $1,003 and has fallen 86.4% since, to $137 in 2025. That places this record below the midpoint for vascular surgery clinicians in FL, where the typical reported total is $6,364.

$3,140in general payments, 2019–2025

Across 50 payments — averaging $62.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bard Peripheral Vascular, Inc.$822
Surmodics, Inc.$440
Lemaitre Vascular, Inc.$375
Medtronic$354
Philips North America LLC$346
W. L. Gore & Associates, Inc.$221
plus $580 from 9 others

$7,272in research payments, 2019–2025

Across 3 payments — averaging $2423.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Humacyte Global, Inc.$7K

What the payments were for

Consulting fees$37512%
Travel & lodging$803%
Food & beverage$2,68586%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bard Peripheral Vascular, Inc.	10	$822
Surmodics, Inc.	8	$440
Lemaitre Vascular, Inc.	1	$375
Medtronic(2 entities)	9	$354
Philips North America LLC	3	$346
W. L. Gore & Associates, Inc.	3	$221
Organogenesis Inc.	2	$142
Getinge USA Sales, LLC	3	$142
Catheter Precision, Inc. FKA Ra Medical Systems, Inc.	2	$74
Aroa Biosurgery Incorporated	2	$63
Kerecis Limited	2	$57
Cook Medical LLC	2	$37
BD	1	$29
Abbott	1	$19
Covidien LP	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VALVULOTOM$375
Sublime 014 Rx PTA Balloon Dilatation Catheter$173
Sublime Radial Access 018 RX PTA Dilatation Catheter$173
Sublime Radial Access Guide Sheath$173
Pounce Thrombectomy System$173
Pounce Venous Thrombectomy System$173
GORE EXCLUDER AAA Endoprosthesis$142
Turbo Elite$125
PuraPly$122
(5044) MCOT$116
(5027) Intact Vascular Und$105

How this compares

$3,140 in reported general payments places this provider in the 30th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$162,465

Medicare patients

228

Services billed

827

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	22	$15,512
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	110	$344
Prednisone	92	$112

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Miami

Juan Fleites VazquezMiami$89K
Tony ShaoMiami$37K
Samuel TapperStuart$1.3M
Mariano ArosemenaBradenton$472K
Manuel Perez IzquierdoOrlando$302K
Erin MooreJacksonville$300K
Rajesh MalikNaples$237K
Charles BaileyTampa$162K
Joseph WasselleMelbourne$161K
Joseph RicottaDelray Beach$156K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →